PROF250117P12500
- 0.00
- 0.000.00%
Profound Medical Newsroom
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $17
Raymond James Initiates Profound Medical(PROF.US) With Buy Rating, Announces Target Price $17
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $17
Lake Street Sticks to Its Buy Rating for Profound Medical (PRN)
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Raises Target Price to $17
Stifel Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $12
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $16.5
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $16.5
Lake Street Remains a Buy on Profound Medical (PRN)
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $16.5
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $16.5
Profound Medical (PRN) Receives a Buy From Stifel Nicolaus
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Raises Target Price to $16.5
Profound Medical (PRN) Receives a Buy From Lake Street
Profound Medical Upgraded at Stifel on Medicare Policy Update
Profound Medical Analyst Ratings
Stifel Upgrades Profound Medical to Buy, Raises Price Target to $12
Buy Rating Affirmed for Profound Medical on Reimbursement and Market Expansion Prospects
Profound Medical Analyst Ratings
Profound Medical Analyst Ratings